Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Progenics Pharmaceuticals Inc.
Progenics Pharmaceuticals shares soared 28.99 percent on volume of over 4 million shares traded Friday to close at $4.36 a share. The company announced their net loss shrunk to $0.3 million for the fourth quarter of 2012, compared to a net loss of $10.7 million a year prior.
Going forward ... (see research report)
Subscribe to News Feeds